Array
(
[id] => 4791735
[patent_doc_number] => 20080292708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Polymeric Adhesive Matrix with Salified Carboxylic Groups for Transdermal Use'
[patent_app_type] => utility
[patent_app_number] => 11/659379
[patent_app_country] => US
[patent_app_date] => 2005-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1605
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20080292708.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659379
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659379 | Polymeric Adhesive Matrix with Salified Carboxylic Groups for Transdermal Use | Jul 5, 2005 | Abandoned |
Array
(
[id] => 5515504
[patent_doc_number] => 20090215811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Novel Pharmaceutical Composition and Its Use in a Method For Treatment of Patients With Upper Respiratory Mucosal Congestion'
[patent_app_type] => utility
[patent_app_number] => 11/922271
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3868
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215811.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922271
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922271 | Pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion | Jun 16, 2005 | Issued |
Array
(
[id] => 4839430
[patent_doc_number] => 20080279915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Matrix-Controlled Transdermal Therapeutic System Based on an Adhesive for Administering Norelgestromin or the Combination Thereof with an Estrogen'
[patent_app_type] => utility
[patent_app_number] => 11/629046
[patent_app_country] => US
[patent_app_date] => 2005-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4388
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629046
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629046 | Matrix-Controlled Transdermal Therapeutic System Based on an Adhesive for Administering Norelgestromin or the Combination Thereof with an Estrogen | Jun 8, 2005 | Abandoned |
Array
(
[id] => 7038916
[patent_doc_number] => 20050158350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Use of licochalcone a or of an extract of radix glycyrrhizae inflatae that contains licochalcone a against postinflammatory hyperpigmentation'
[patent_app_type] => utility
[patent_app_number] => 10/966036
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5871
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158350.pdf
[firstpage_image] =>[orig_patent_app_number] => 10966036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/966036 | Use of licochalcone a or of an extract of radix glycyrrhizae inflatae that contains licochalcone a against postinflammatory hyperpigmentation | Oct 17, 2004 | Abandoned |
Array
(
[id] => 5829195
[patent_doc_number] => 20060063800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments'
[patent_app_type] => utility
[patent_app_number] => 10/542244
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1660
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542244 | Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments | Dec 9, 2003 | Issued |